Celldex Therapeutics, Inc. (CLDX) income statement
CLDXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$27.42−0.54 (-1.93%)
Close on Nov 20, 2026Market cap $2.15BP/E –Yield –
Celldex Therapeutics, Inc. financial ratios
See a number that looks wrong?